This week we saw the Antengene Corporation Limited (HKG:6996) share price climb by 11%. But that's not enough to compensate for the decline over the last twelve months. Specifically, the stock price slipped by 58% in that time. Some might say the recent bounce is to be expected after such a bad drop. It may be that the fall was an overreaction.
On a more encouraging note the company has added CN¥451m to its market cap in just the last 7 days, so let's see if we can determine what's driven the one-year loss for shareholders.
Check out our latest analysis for Antengene
Given that Antengene didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally expect to see good revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).SEHK:6996 Earnings and Revenue Growth May 16th 2022
If you are thinking of buying or selling Antengene stock, you should check out this FREE detailed report on its balance sheet .
A Different Perspective
We doubt Antengene shareholders are happy with the loss of 58% over twelve months. That falls short of the market, which lost 22%. There's no doubt that's a disappointment, but the stock may well have fared better in a stronger market. Putting aside the last twelve months, it's good to see the share price has rebounded by 9.6%, in the last ninety days. This could just be a bounce because the selling was too aggressive, but fingers crossed it's the start of a new trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 2 warning signs for Antengene that you should be aware of before investing here.
Of course Antengene may not be the best stock to buy. So you may wish to see this free collection of growth stocks .
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on HK exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.